Southeast Asia Diabetes Devices Market Size, Share & Trends Analysis Report By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel (Diabetes Clinics/Centers), By End Use (Diagnostic Centers, Homecare), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Southeast Asia Diabetes Devices Market Growth & Trends
The Southeast Asia diabetes devices market size is anticipated t%li%reach USD 3.58 billion by 2030, registering a CAGR of 9.36% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The market is growing due t%li%the rising occurrence of diabetes linked t%li%aging, obesity, and poor lifestyle choices. Obesity rates in SEA have surged by 40% from 1990 t%li%2013. Forecasts indicate that by 2030, over 52.4 million adults and 21 million youth in the region will be obese. As obesity rates continue t%li%increase in the region, the incidence of diabetes is als%li%expected t%li%rise, driving the demand for effective diabetes management devices. The excessive body fat associated with obesity can lead t%li%insulin resistance, a contributor t%li%the onset of diabetes, further exacerbating the already high prevalence of the disease in Southeast Asia.
Diabetes devices play a pivotal role in enhancing the care and management of diabetic patients. The growing demand for these devices is driven by their ability t%li%prevent prolonged hospital stays and reduce mortality rates among individuals with diabetes. The proactive approach enabled by diabetes devices can help prevent serious complications associated with uncontrolled blood sugar levels. By allowing for early detection of hypo- or hyperglycemia, these devices enable prompt action t%li%stabilize glucose levels before they escalate int%li%critical situations. This proactive monitoring can significantly reduce the risk of diabetic emergencies requiring hospitalization, ultimately improving patient outcomes and quality of life.
Increasing awareness about diabetes management through educational campaigns and programs plays a vital role in driving market growth. Educating patients about the importance of regular monitoring and adherence t%li%treatment regimens boosts the demand for related medical devices. For instance, in April 2024, Embecta, a New Jersey company, launched a diabetes education program named emERGE in the Asia-Pacific region. The program is set t%li%commence in 11 countries, including Singapore, Thailand, Vietnam, Australia, South Korea, Japan, Indonesia, Malaysia, the Philippines, and New Zealand. The primary goal of this initiative is t%li%provide educational benefits t%li%around 5,000 healthcare professionals, such as practitioners, diabetes nurse educators, and lead pharmacists, through a series of four interactive webinars.
Southeast Asia Diabetes Devices Market Report Highlights
Southeast Asia Diabetes Devices Market Growth & Trends
The Southeast Asia diabetes devices market size is anticipated t%li%reach USD 3.58 billion by 2030, registering a CAGR of 9.36% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The market is growing due t%li%the rising occurrence of diabetes linked t%li%aging, obesity, and poor lifestyle choices. Obesity rates in SEA have surged by 40% from 1990 t%li%2013. Forecasts indicate that by 2030, over 52.4 million adults and 21 million youth in the region will be obese. As obesity rates continue t%li%increase in the region, the incidence of diabetes is als%li%expected t%li%rise, driving the demand for effective diabetes management devices. The excessive body fat associated with obesity can lead t%li%insulin resistance, a contributor t%li%the onset of diabetes, further exacerbating the already high prevalence of the disease in Southeast Asia.
Diabetes devices play a pivotal role in enhancing the care and management of diabetic patients. The growing demand for these devices is driven by their ability t%li%prevent prolonged hospital stays and reduce mortality rates among individuals with diabetes. The proactive approach enabled by diabetes devices can help prevent serious complications associated with uncontrolled blood sugar levels. By allowing for early detection of hypo- or hyperglycemia, these devices enable prompt action t%li%stabilize glucose levels before they escalate int%li%critical situations. This proactive monitoring can significantly reduce the risk of diabetic emergencies requiring hospitalization, ultimately improving patient outcomes and quality of life.
Increasing awareness about diabetes management through educational campaigns and programs plays a vital role in driving market growth. Educating patients about the importance of regular monitoring and adherence t%li%treatment regimens boosts the demand for related medical devices. For instance, in April 2024, Embecta, a New Jersey company, launched a diabetes education program named emERGE in the Asia-Pacific region. The program is set t%li%commence in 11 countries, including Singapore, Thailand, Vietnam, Australia, South Korea, Japan, Indonesia, Malaysia, the Philippines, and New Zealand. The primary goal of this initiative is t%li%provide educational benefits t%li%around 5,000 healthcare professionals, such as practitioners, diabetes nurse educators, and lead pharmacists, through a series of four interactive webinars.
Southeast Asia Diabetes Devices Market Report Highlights
- In 2023, the insulin delivery devices segment dominated the market with a share of over 50.00% and is expected t%li%grow over the forecast period due t%li%patient preferences, treatment outcomes, and healthcare professional recommendations
- Based on distribution channels, the hospital pharmacies segment held the largest share of around 53.00% in 2023. This can be attributed t%li%the accessibility of hospital pharmacies t%li%patients wh%li%visit healthcare facilities for various needs, including diabetes management
- The retail pharmacies segment is expected t%li%grow at the fastest CAGR during the forecast period due t%li%the expanding network of retail pharmacies in the region
- The hospital pharmacy end use segment held a majority share of the market of over 40.00% in 2023. This is attributed t%li%the number of patients with diabetes being hospitalized
- The diagnostic centers segment is expected t%li%grow at the fastest CAGR over the forecast period due t%li%their ability t%li%provide quick and accurate results
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Distribution Channel
1.2.3. End Use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Distribution Channel outlook
2.2.3. End Use outlook
2.3. Competitive Insights
CHAPTER 3. SOUTHEAST ASIA DIABETES DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increase in diabetic prevalence
3.2.1.2. Technological advancements
3.2.1.3. Initiatives by government organizations and NGOs
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations policies and regulations
3.2.2.2. High cost of devices
3.3. Southeast Asia Diabetes Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. SOUTHEAST ASIA DIABETES DEVICES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Modality Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Southeast Asia Diabetes Devices Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5. BGM Devices
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Self-Monitoring Devices
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.2. Blood Glucose Monitoring Devices
4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.3. Testing Strips
4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.4. Lancets
4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Continuous Glucose Monitoring Devices
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.2. Sensors
4.5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.3. Transmitter
4.5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.4. Receiver
4.5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Insulin Delivery Devices
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Pumps
4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Pens
4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Syringes
4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.5. Jet Injector
4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. SOUTHEAST ASIA DIABETES DEVICES MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
5.1. Distribution Channel Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Southeast Asia Diabetes Devices Market by Distribution Channel Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4.1. Hospital Pharmacies
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Retail Pharmacies
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Diabetes Clinics/Centers
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.3. Online Pharmacies
5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.4. Others
5.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. SOUTHEAST ASIA DIABETES DEVICES MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Southeast Asia Diabetes Devices Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.4.1. Hospitals
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Diagnostic Centers
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Homecare
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company heat map analysis, 2023
7.4. Company Profiles
7.4.1. Medtronic plc.
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Abbott Laboratories
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. F.Hoffmann-La-Ltd.
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Bayer AG
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Lifescan, Inc.
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. B Braun Melsungen AG
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Dexcom Inc.
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Insulet Corporation
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Ypsomed Holdings
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Companion Medical
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Sanofi
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Valeritas Holding Inc.
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
7.4.13. Novo Nordisk
7.4.13.1. Company overview
7.4.13.2. Financial performance
7.4.13.3. Product benchmarking
7.4.13.4. Strategic initiatives
7.4.14. Arkay, Inc.
7.4.14.1. Company overview
7.4.14.2. Financial performance
7.4.14.3. Product benchmarking
7.4.14.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Distribution Channel
1.2.3. End Use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Distribution Channel outlook
2.2.3. End Use outlook
2.3. Competitive Insights
CHAPTER 3. SOUTHEAST ASIA DIABETES DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increase in diabetic prevalence
3.2.1.2. Technological advancements
3.2.1.3. Initiatives by government organizations and NGOs
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations policies and regulations
3.2.2.2. High cost of devices
3.3. Southeast Asia Diabetes Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. SOUTHEAST ASIA DIABETES DEVICES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Modality Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Southeast Asia Diabetes Devices Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5. BGM Devices
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Self-Monitoring Devices
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.2. Blood Glucose Monitoring Devices
4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.3. Testing Strips
4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.4. Lancets
4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Continuous Glucose Monitoring Devices
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.2. Sensors
4.5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.3. Transmitter
4.5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.4. Receiver
4.5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Insulin Delivery Devices
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Pumps
4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Pens
4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Syringes
4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.5. Jet Injector
4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. SOUTHEAST ASIA DIABETES DEVICES MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
5.1. Distribution Channel Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Southeast Asia Diabetes Devices Market by Distribution Channel Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4.1. Hospital Pharmacies
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Retail Pharmacies
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Diabetes Clinics/Centers
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.3. Online Pharmacies
5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.4. Others
5.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. SOUTHEAST ASIA DIABETES DEVICES MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Southeast Asia Diabetes Devices Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.4.1. Hospitals
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Diagnostic Centers
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Homecare
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company heat map analysis, 2023
7.4. Company Profiles
7.4.1. Medtronic plc.
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Abbott Laboratories
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. F.Hoffmann-La-Ltd.
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Bayer AG
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Lifescan, Inc.
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. B Braun Melsungen AG
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Dexcom Inc.
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Insulet Corporation
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Ypsomed Holdings
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Companion Medical
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Sanofi
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Valeritas Holding Inc.
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
7.4.13. Novo Nordisk
7.4.13.1. Company overview
7.4.13.2. Financial performance
7.4.13.3. Product benchmarking
7.4.13.4. Strategic initiatives
7.4.14. Arkay, Inc.
7.4.14.1. Company overview
7.4.14.2. Financial performance
7.4.14.3. Product benchmarking
7.4.14.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 Southeast Asia Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 3 Southeast Asia Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 4 Southeast Asia Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 5 Indonesia Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 6 Indonesia Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 7 Indonesia Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 8 Thailand Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 9 Thailand Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 10 Thailand Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 11 Philippines Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 12 Philippines Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 13 Philippines Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 14 Malaysia Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 15 Malaysia Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 16 Malaysia Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 17 Vietnam Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 18 Vietnam Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Vietnam Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 20 Myanmar Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 21 Myanmar Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 22 Myanmar Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 23 Singapore Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 24 Singapore Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 25 Singapore Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 Southeast Asia Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 3 Southeast Asia Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 4 Southeast Asia Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 5 Indonesia Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 6 Indonesia Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 7 Indonesia Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 8 Thailand Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 9 Thailand Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 10 Thailand Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 11 Philippines Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 12 Philippines Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 13 Philippines Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 14 Malaysia Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 15 Malaysia Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 16 Malaysia Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 17 Vietnam Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 18 Vietnam Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Vietnam Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 20 Myanmar Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 21 Myanmar Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 22 Myanmar Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 23 Singapore Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 24 Singapore Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 25 Singapore Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig.1 Market research process
Fig.2 Data triangulation techniques
Fig.3 Primary research pattern
Fig.4 Primary interviews in North America
Fig.5 Primary interviews in Europe
Fig.6 Primary interviews in APAC
Fig.7 Primary interviews in Latin America
Fig.8 Primary interviews in MEA
Fig.9 Market research approaches
Fig.10 Value-chain-based sizing & forecasting
Fig.11 QFD modeling for market share assessment
Fig.12 Market formulation & validation
Fig.13 Coagulants market: market outlook
Fig.14 Coagulants competitive insights
Fig.15 Parent market outlook
Fig.16 Related/ancillary market outlook
Fig.17 Coagulants market driver impact
Fig.18 Coagulants market restraint impact
Fig.19 Coagulants market: Product movement analysis
Fig.20 Coagulants market: Product outlook and key takeaways
Fig.21 Topical coagulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig.22 Absorbable gelatin market estimates and forecast, 2018 - 2030 (USD Million)
Fig.23 Oxidized cellulose market estimates and forecast, 2018 - 2030 (USD Million)
Fig.24 Microfibrillar collagen market estimates and forecast, 2018 - 2030 (USD Million)
Fig.25 Other topical coagulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig.26 Systemic coagulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig.27 Vitamin K market estimates and forecast, 2018 - 2030 (USD Million)
Fig.28 Protamine market estimates and forecast, 2018 - 2030 (USD Million)
Fig.29 Desmopressin market estimates and forecast, 2018 - 2030 (USD Million)
Fig.30 Fibrinogen market estimates and forecast, 2018 - 2030 (USD Million)
Fig.31 Other systemic coagulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig.32 Hemostatics market estimates and forecast, 2018 - 2030 (USD Million)
Fig.33 Coagulants market: Application product movement analysis
Fig.34 Coagulants market: Application product outlook and key takeaways
Fig.35 Surgeries market estimates and forecast, 2018 - 2030 (USD Million)
Fig.36 Trauma Cases market estimates and forecast, 2018 - 2030 (USD Million)
Fig.37 Hemophilia market estimates and forecast, 2018 - 2030 (USD Million)
Fig.38 Bleeding Disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig.39 Other Applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig.40 Coagulants market: Route of administration movement analysis
Fig.41 Coagulants market: Route of administration outlook and key takeaways
Fig.42 Topical Administration market estimates and forecast, 2018 - 2030 (USD Million)
Fig.43 Parenteral Administration market estimates and forecast, 2018 - 2030 (USD Million)
Fig.44 Oral Administration market estimates and forecast, 2018 - 2030 (USD Million)
Fig.45 Global Coagulants market: Regional outlook and key takeaways
Fig.46 Global Coagulants market share and leading players
Fig.47 North America, by country
Fig.48 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.49 U.S. key country dynamics
Fig.50 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.51 Canada key country dynamics
Fig.52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.53 Mexico key country dynamics
Fig.54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.55 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.56 UK key country dynamics
Fig.57 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.58 Germany key country dynamics
Fig.59 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.60 France key country dynamics
Fig.61 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.62 Italy key country dynamics
Fig.63 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.64 Spain key country dynamics
Fig.65 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.66 Denmark key country dynamics
Fig.67 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.68 Sweden key country dynamics
Fig.69 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.70 Norway key country dynamics
Fig.71 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.72 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.73 China key country dynamics
Fig.74 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.75 Japan key country dynamics
Fig.76 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.77 India key country dynamics
Fig.78 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.79 Thailand key country dynamics
Fig.80 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.81 South Korea key country dynamics
Fig.82 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.83 Australia key country dynamics
Fig.84 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.85 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.86 Brazil key country dynamics
Fig.87 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.88 Argentina key country dynamics
Fig.89 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.90 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.91 South Africa key country dynamics
Fig.92 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.93 Saudi Arabia key country dynamics
Fig.94 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.95 UAE key country dynamics
Fig.96 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.97 Kuwait key country dynamics
Fig.98 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.99 Market share of key market players- coagulants market
Fig.1 Market research process
Fig.2 Data triangulation techniques
Fig.3 Primary research pattern
Fig.4 Primary interviews in North America
Fig.5 Primary interviews in Europe
Fig.6 Primary interviews in APAC
Fig.7 Primary interviews in Latin America
Fig.8 Primary interviews in MEA
Fig.9 Market research approaches
Fig.10 Value-chain-based sizing & forecasting
Fig.11 QFD modeling for market share assessment
Fig.12 Market formulation & validation
Fig.13 Coagulants market: market outlook
Fig.14 Coagulants competitive insights
Fig.15 Parent market outlook
Fig.16 Related/ancillary market outlook
Fig.17 Coagulants market driver impact
Fig.18 Coagulants market restraint impact
Fig.19 Coagulants market: Product movement analysis
Fig.20 Coagulants market: Product outlook and key takeaways
Fig.21 Topical coagulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig.22 Absorbable gelatin market estimates and forecast, 2018 - 2030 (USD Million)
Fig.23 Oxidized cellulose market estimates and forecast, 2018 - 2030 (USD Million)
Fig.24 Microfibrillar collagen market estimates and forecast, 2018 - 2030 (USD Million)
Fig.25 Other topical coagulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig.26 Systemic coagulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig.27 Vitamin K market estimates and forecast, 2018 - 2030 (USD Million)
Fig.28 Protamine market estimates and forecast, 2018 - 2030 (USD Million)
Fig.29 Desmopressin market estimates and forecast, 2018 - 2030 (USD Million)
Fig.30 Fibrinogen market estimates and forecast, 2018 - 2030 (USD Million)
Fig.31 Other systemic coagulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig.32 Hemostatics market estimates and forecast, 2018 - 2030 (USD Million)
Fig.33 Coagulants market: Application product movement analysis
Fig.34 Coagulants market: Application product outlook and key takeaways
Fig.35 Surgeries market estimates and forecast, 2018 - 2030 (USD Million)
Fig.36 Trauma Cases market estimates and forecast, 2018 - 2030 (USD Million)
Fig.37 Hemophilia market estimates and forecast, 2018 - 2030 (USD Million)
Fig.38 Bleeding Disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig.39 Other Applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig.40 Coagulants market: Route of administration movement analysis
Fig.41 Coagulants market: Route of administration outlook and key takeaways
Fig.42 Topical Administration market estimates and forecast, 2018 - 2030 (USD Million)
Fig.43 Parenteral Administration market estimates and forecast, 2018 - 2030 (USD Million)
Fig.44 Oral Administration market estimates and forecast, 2018 - 2030 (USD Million)
Fig.45 Global Coagulants market: Regional outlook and key takeaways
Fig.46 Global Coagulants market share and leading players
Fig.47 North America, by country
Fig.48 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.49 U.S. key country dynamics
Fig.50 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.51 Canada key country dynamics
Fig.52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.53 Mexico key country dynamics
Fig.54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.55 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.56 UK key country dynamics
Fig.57 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.58 Germany key country dynamics
Fig.59 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.60 France key country dynamics
Fig.61 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.62 Italy key country dynamics
Fig.63 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.64 Spain key country dynamics
Fig.65 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.66 Denmark key country dynamics
Fig.67 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.68 Sweden key country dynamics
Fig.69 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.70 Norway key country dynamics
Fig.71 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.72 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.73 China key country dynamics
Fig.74 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.75 Japan key country dynamics
Fig.76 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.77 India key country dynamics
Fig.78 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.79 Thailand key country dynamics
Fig.80 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.81 South Korea key country dynamics
Fig.82 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.83 Australia key country dynamics
Fig.84 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.85 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.86 Brazil key country dynamics
Fig.87 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.88 Argentina key country dynamics
Fig.89 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.90 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.91 South Africa key country dynamics
Fig.92 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.93 Saudi Arabia key country dynamics
Fig.94 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.95 UAE key country dynamics
Fig.96 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.97 Kuwait key country dynamics
Fig.98 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.99 Market share of key market players- coagulants market
